News Releases

This section contains information and press releases about Boston Scientific. Press releases are listed in chronological order and archived by year. Information should be considered accurate as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Boston Scientific is not obligated to update the press releases and information contained in this section of the website.

Click here to access archived Guidant press releases.

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004

2004 Archives

	Dec 31, 2004 Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2004 and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and for the year ended December 31, 2004 at a meeting with... More
	Dec 30, 2004 Boston Scientific to Donate $100,000 to Tsunami Relief (December 30, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is donating $100,000 to the Red Cross for tsunami relief. The money is being directed to the Red Cross'... More
	Dec 20, 2004 Boston Scientific Announces Management Expansion (December 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced an expansion of its management structure designed to position the Company for continued growth and success. The... More
	Dec 16, 2004 Boston Scientific Enters Into Definitive Agreement to Acquire Advanced Stent Technologies, Inc. (December 16, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into a definitive agreement to acquire Advanced Stent Technologies, Inc. (AST) of Pleasanton,... More
	Dec 2, 2004 Boston Scientific Comments on Ruling on Preliminary Motions in Medinol Contract Case (December 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today commented on a ruling by the U.S. District Court for the Southern District of New York on preliminary motions in a breach of... More
	Nov 29, 2004 Boston Scientific Announces Medicare Reimbursement Codes for Intravascular Ultrasound (IVUS) Procedures (November 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Intravascular Ultrasound (IVUS) procedures have been recognized for payment under a new Medicare... More
	Nov 24, 2004 Boston Scientific to Participate in Lazard Freres First Annual Life Sciences Conference (November 24, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lazard Frères First Annual Life Sciences Conference, which will take place November 30 and... More
	Nov 23, 2004 Boston Scientific Exercises Right to Obtain Exclusive Paclitaxel License from Angiotech (November 23, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it had exercised its right under an existing licensing agreement with Angiotech Pharmaceuticals, Inc. (NASDAQ:... More
	Nov 22, 2004 French Government Expands Reimbursement for TAXUS(TM) Express2(TM) Paclitaxel-Eluting Stent System (November 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the French government that it has added new categories of "high-risk" patients to the... More
	Nov 18, 2004 Boston Scientific Announces Completion of Public Offering of $500 Million Aggregate Principal Amount of Senior Notes (November 18, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its public offering of $250 million aggregate principal amount of its 4.250 percent senior notes... More
	Nov 16, 2004 Boston Scientific Announces Strategic Alliance with REVA Medical, Inc. (November 16, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has made an equity investment in -- and secured an exclusive option to purchase -- REVA Medical, Inc., a... More
	Nov 15, 2004 Boston Scientific Announces Public Offering of Senior Notes (November 15, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today the launch of a public offering of two series of its senior notes under the Company's existing shelf registration... More
	Nov 12, 2004 Boston Scientific to Participate in Credit Suisse First Boston Healthcare Conference (November 12, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Credit Suisse First Boston Healthcare Conference 2004, which is being held November 17-19 in... More
	Nov 8, 2004 Boston Scientific Announces Resumption of Distribution of Advanced Bionics Cochlear Auditory Implant (November 8, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its subsidiary, Advanced Bionics Corporation of Valencia, California, is resuming worldwide distribution of its... More
	Nov 5, 2004 Boston Scientific Highlights TAXUS Data at American Heart Association Meeting (November 5, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its TAXUS™ Express2™ paclitaxel-eluting coronary stent system will be the subject of 15 presentations at... More
	Nov 4, 2004 Boston Scientific to Participate in CIBC Conference (November 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Fifteenth Annual Healthcare Conference, which is being held November 8-10 in... More
	Nov 2, 2004 Boston Scientific Announces Interim Treatment Satisfaction Data from Three-Year Follow-Up Study and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced interim results from a 200-patient clinical trial to evaluate the effectiveness, safety and... More
	Nov 2, 2004 Boston Scientific Announces Three-Month Efficacy Data from Randomized Controlled Trial for Enteryx® Procedure and Orlando, FL (November 2, 2004)-- Boston Scientific Corporation (NYSE: BSX) today announced results supporting the efficacy of the Enteryx Procedure in relieving the symptoms of... More
	Nov 2, 2004 Boston Scientific Announces Two-Year Follow-Up Data from Enteryx® Procedure Clinical Trial and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its ongoing Enteryx Procedure clinical trial for the treatment of... More
	Nov 1, 2004 Uterine Fibroid Treatment Option 'Safe and Effective,' According to British Health Authority Advisory Committee (November 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the National Institute for Clinical... More
	Oct 28, 2004 Boston Scientific Announces Launch of Broad Line of Mid-Urethral Sling Products (October 28, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has launched a full line of mid-urethral sling products for the treatment of female stress urinary... More
	Oct 27, 2004 Boston Scientific Announces Start of Enrollment in ARRIVE 2 Drug-Eluting Stent Registry (October 27, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the ARRIVE 2 registry program, which plans to enroll 5,000 patients at approximately 60... More
	Oct 26, 2004 Boston Scientific Announces Share Repurchase Authorization (October 26, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Board of Directors has authorized the repurchase of up to 50 million shares of the Company's common stock... More
	Oct 19, 2004 Boston Scientific Announces Third Quarter Results (October 19, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2004. Highlights: Net sales of $1.482 billion, an... More
	Oct 13, 2004 Boston Scientific Announces FDA Clearance for New IQ™ Guide Wire (October 13, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new coronary... More
1-25 26-50 51-75 76-99